BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Dolmans MM, Cacciottola L, Donnez J. Conservative Management of Uterine Fibroid-Related Heavy Menstrual Bleeding and Infertility: Time for a Deeper Mechanistic Understanding and an Individualized Approach. J Clin Med 2021;10:4389. [PMID: 34640407 DOI: 10.3390/jcm10194389] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Maidarti M, Anggraheny BAR, Umarghanies SS, Garinasih PD, Harzif AK, Simatupang ONN. Severe chronic pelvic pain due to cystic degeneration of subserosal uterine fibroid with type 2 diabetes and obesity: Serial case report. Int J Surg Case Rep 2023;104:107934. [PMID: 36801770 DOI: 10.1016/j.ijscr.2023.107934] [Reference Citation Analysis]
2 Vannuccini S, Clemenza S, Cassioli E, Rossi E, Castellini G, Ricca V, Petraglia F. Uterine Fibroids, Perceived Stress, and Menstrual Distress: a Key Role of Heavy Menstrual Bleeding. Reprod Sci 2022. [DOI: 10.1007/s43032-022-01126-3] [Reference Citation Analysis]
3 Akram S, Akmal A, Ahmad S, Ahmad H, Roohi N. Clinicopathological Patterns and Biochemical Markers in Serum of Uterine Leiomyoma Patients. Albus Scientia 2022;2022:1-7. [DOI: 10.56512/as.2022.2.e221025] [Reference Citation Analysis]
4 Donnez J, Carmona F, Maitrot-Mantelet L, Dolmans MM, Chapron C. Uterine disorders and iron deficiency anemia. Fertil Steril 2022;118:615-24. [PMID: 36182260 DOI: 10.1016/j.fertnstert.2022.08.011] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Donnez J, Taylor HS, Stewart EA, Bradley L, Marsh E, Archer D, Al-Hendy A, Petraglia F, Watts N, Gotteland JP, Bestel E, Terrill P, Loumaye E, Humberstone A, Garner E. Linzagolix with and without hormonal add-back therapy for the treatment of symptomatic uterine fibroids: two randomised, placebo-controlled, phase 3 trials. Lancet 2022;400:896-907. [PMID: 36116480 DOI: 10.1016/S0140-6736(22)01475-1] [Cited by in Crossref: 8] [Cited by in F6Publishing: 2] [Article Influence: 8.0] [Reference Citation Analysis]
6 Keam SJ. Linzagolix: First Approval. Drugs 2022. [PMID: 35997940 DOI: 10.1007/s40265-022-01753-9] [Reference Citation Analysis]